Clinical updates in advancements of treatment of TNBC, HR+, HER2+, HER2-Low breast cancer ESMO Congress Updates - Germany

Requirements: Group leaders should be experts in the treatment of TNBC, HR+, HER2+, HER2-Low BC (breast cancer).

If you already have a Gather-ed account, please log in here

Email:
Password:

Apply for Group Leader

Step 1 of 3